Rutgers Study Challenges FDA Warning on Antiseizure Drug

Rutgers study challenges FDA warning on antiseizure drug

Rutgers Health researchers found that lamotrigine, a widely prescribed antiseizure medication, to be safe in older adults with epilepsy, contrary to a safety warning by the Food and Drug Administration (FDA).

Researchers challenge FDA warning on common epilepsy drug

Rutgers Health researchers found that lamotrigine, a widely prescribed antiseizure medication, to be safe in older adults with epilepsy, contrary to a safety warning by the Food and Drug Administration (FDA). The study has been published in Neurology.

FDA Withdraws Defense of Laboratory Developed Test Rule Amid Speculation on Research Use Only Product Oversight

The U.S. Food and Drug Administration (FDA) has officia […] The post FDA Withdraws Defense of Laboratory Developed Test Rule Amid Speculation on Research Use Only Product Oversight first appeared on GeneOnline News. The post FDA Withdraws Defense of Laboratory Developed Test Rule Amid Speculation on Research Use Only Product Oversight appeared first on GeneOnline News.